Últimas noticias sobre Raytech Holding (NASDAQ:RAY) Bolsa

Raytech Holding

Raytech Holding Ltd is principally engaged in product designing and manufacturing of various product ranges such as Hair Care, Men's Care and Women's Care products. It has sourced and wholesaled a wide range of personal care electrical appliances, which can be broadly classified into seven categories: hair styling series, including hair dryer, hair straightener and curling iron; trimmer series, including facial shaver, nose trimmer and eyebrow trimmer; eyelash curler; neck care series; nail care series; tooling and other personal care appliances such as body and facial brush, reset brush, callus remover, sonic peeling, handy fan and others. Raytech manufactures products under OEM and ODM.

Raytech Holding Limited - ordinary shares

Raytech Holding Ltd

Raydium - United States Dollar

Erayak Power Solution Group Inc. - Class A Ordinary Shares

Erayak Power Solution Group Inc

Rayliant Quantamental China Equity ETF

The Advisors' Inner Circle Fund III Rayliant Quantitative Developed Market Equity ETF

Rayliant Quantamental Emerging Market ex-China Equity ETF

The Advisors' Inner Circle Fund III Rayliant SMDAM Japan Equity ETF

Global X Solar ETF

Rayont Inc

The recent U.S. presidential election results, including a Republican sweep, have raised questions about the future of renewable energy under President-elect Donald Trump&#8217;s leadership.
Morgan Stanley&#8217;s report evaluates the economic impact on renewables under various policy scenarios and its effects on earnings.
The analyst has adjusted its view on the clean tech industry to &#8220;In-Line&#8221; from &#8220;Attractive.&#8221;
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41880110/solar-renewables-stocks-crash-after-trump-win-should-you-buy-now-at-cheap-valuations" rel="noreferrer noopener">Solar, Renewables Stocks Crash After Trump Win: Should You Buy Now At Cheap Valuations?</a>
While long-term demand for renewables is likely stronger than current market perceptions, near-term growth prospects have become less clear due to new uncertainties.
It&#8217;s important to remember that these new uncertainties add to the already difficult environment facing the clean energy sector, dealing with issues such as permitting and interconnection delays, funding challenges, and intense competition that have hurt profitability.
Uncertainty about the Inflation Reduction Act (IRA), tariffs, and interest rates has significantly impacted clean fuel valuations.
Morgan Stanley writes that clear guidance on the IRA is essential for clean tech valuations to rebound. However, this may take time since it will likely be linked to discussions about the Tax Cuts and Job Act&nbsp;(TCJA), which is set to expire at the end of 2025.
Morgan Stanley recommends investing in stocks with high-quality and durable growth/ margins, with a clear catalyst path and/or strong balance sheet to weather any near-term volatility in growth and/or profitability.
<ul>
<li>The analyst maintains an Overweight rating on GE Vernova Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>), First Solar Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>), and Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>).</li>
</ul>
However, the analyst has downgraded three cleantech stocks from Equal-weight to Underweight, including:
<ul>
<li>SolarEdge Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>): The analyst reduced the price target from $23 to $9, citing slower profitability due to decreased European demand and tough competition from cheaper Chinese manufacturers. As a result, the company is not expected to break even on <a href="https://www.benzinga.com/quote/SEDG/analyst-ratings" target="_blank" rel="noreferrer noopener">EBITDA until after 2026</a>. At last check Friday, the stock was trading 13.2% lower at $11.13.</li>
<li>Maxeon Solar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAXN#NASDAQ">MAXN</a>): Morgan Stanley anticipates a slow recovery to profitability due to increasing competition in Europe&#8217;s utility-scale solar market, which will likely keep pushing prices down. The analyst maintains the <a href="https://www.benzinga.com/quote/MAXN/analyst-ratings" target="_blank" rel="noreferrer noopener">price target of $4</a>. Additionally, recent customer losses in the U.S. residential market could make maintaining market share and premium pricing harder. Stock is trading 10.08% lower at $10.08 at last check Friday.</li>
<li>TPI Composites, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPIC#NASDAQ">TPIC</a>): The analyst notes an uncertainty about how quickly the U.S. wind market will recover, mainly due to challenges in securing financing and recent issues with design and inspections as the industry shifts to larger blade sizes. Morgan Stanley has cut the <a href="https://www.benzinga.com/quote/TPIC/analyst-ratings" target="_blank" rel="noreferrer noopener">price target from $4 to $2</a>. Stock is down 8.82% at $2.16 at the last check Friday.</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/24/11/42012689/life-insurance-firm-aegon-trades-higher-as-capital-ratios-remain-solid" target="_blank" rel="noreferrer noopener">Life Insurance Firm Aegon Trades Higher As Capital Ratios&#8217; Remain Solid&#8217;</a></li>
</ul>
Photo via Shutterstock

Analyst Color

Government

Large Cap

News

Downgrades

Price Target

Analyst Ratings

Movers

Trading Ideas

General

FSLR

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

SEDG

TPIC

Trump's Win, Economic Challenges Lead to Tougher Outlook for Renewable Energy Stocks: Morgan Stanley

Wells Fargo analyst Derek Archila maintains Kyverna Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KYTX#NASDAQ">KYTX</a>) with a Overweight and lowers the price target from $44 to $24.

KYTX

Wells Fargo Maintains Overweight on Kyverna Therapeutics, Lowers Price Target to $24

Wells Fargo analyst Roger Read maintains Coterra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRA#NYSE">CTRA</a>) with a Overweight and raises the price target from $32 to $35.

CTRA

Wells Fargo Maintains Overweight on Coterra Energy, Raises Price Target to $35

Guggenheim analyst Michael Schmidt maintains Zentalis Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZNTL#NASDAQ">ZNTL</a>) with a Buy and lowers the price target from $12 to $8.

ZNTL

Guggenheim Maintains Buy on Zentalis Pharma, Lowers Price Target to $8

Macro Economic Events

Economics

Federal Reserve

Fed's Goolsbee Says Everything Is Always On The Fed Policy Table; Inflation Numbers Have To Keep Improving; If Started To See Reversal On Inflation Progress, Would Have To Figure Out If It Is A Bump; Not A Lot Has Changed On That In Last Couple Weeks; Recent Inflation Has Been A Little Higher Than Target, If That Is Extended, It's Too High; There's A Lot Of Volatility On Inflation Data Series

Telsey Advisory Group analyst Dana Telsey maintains Tapestry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>) with a Outperform and raises the price target from $58 to $67.

Telsey Advisory Group Maintains Outperform on Tapestry, Raises Price Target to $67

Guggenheim analyst Robert Drbul maintains Tapestry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>) with a Buy and raises the price target from $60 to $70.

Guggenheim Maintains Buy on Tapestry, Raises Price Target to $70

Fed's Goolsbee Asked About A December Rate-Cut Pause, Says He Doesn't Like Tying Our Hands, Still More Data To Come; Markets React Immediately And In Most Extreme Terms; That's Not The Fed Timetable; Fed Needs To Focus On Longer Trends; We Are Going To Be Looking At Rate Cuts Along The Lines Of September Fed Policymaker Projections; Personally Comfortable With Not Charging Right Towards Neutral, Slow Down As We Approach It

On Thursday, Bluebird Bio Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLUE#NASDAQ">BLUE</a>) reported a third-quarter EPS loss of 31 cents, compared to a loss of 80 cents a year ago, beating the <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b41967541/bluebird-bio-reports-third-quarter-2024-results-and-highlights-operational-progress-and-2024-guida" rel="noreferrer noopener">consensus loss of 36 cents</a>.
The gene therapy company reported sales of $10.6 million, down from $12.39 million, missing the consensus of $18.1 million.
The company&#8217;s cash, cash equivalents, and restricted cash balance were approximately&nbsp;$118.7 million, which is expected to provide a cash runway into the first quarter of 2025.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/10/41290857/worries-mount-over-cancer-risks-in-bluebird-bios-gene-therapy" rel="noreferrer noopener">Worries Mount Over Cancer Risks in Bluebird Bio&#8217;s Gene Therapy</a>
The company anticipates quarterly cash flow break-even in the second half of 2025, assuming it scales to approximately 40 drug product deliveries per quarter and obtains additional cash resources to extend its runway.
JP Morgan downgraded Bluebird after the third-quarter results. The analyst notes a reduced cash runway to &#8220;into 1Q25&#8221; from &#8220;into 2Q25.&#8221;
JP Morgan highlights that Bluebird did achieve the milestone of its first Lyfgenia infusion during the quarter (and revenue recognition) and continues to increase the pace of patient starts (cell collections) across its portfolio but is doing so against a backdrop of continued negative gross margins.
<ul>
<li>57 patient starts completed to date in 2024 (35 Zynteglo, 17 Lyfgenia, 5 Skysona).</li>
<li>Seventeen additional starts are scheduled through the remainder of 2024.</li>
</ul>
&#8220;Altogether presenting few avenues to emerge from remaining a going concern,&#8221; the analyst says. JP Morgan has downgraded from <a href="https://www.benzinga.com/quote/BLUE/analyst-ratings" target="_blank" rel="noreferrer noopener">Neutral to Underweight</a>.
The analyst writes that the proxy vote did not gather enough support to approve a reverse stock split and increase the number of shares available for issuance. This outcome effectively eliminates equity financing as an option for raising capital.
In September, Bluebird bio implemented a restructuring to optimize its cost structure and enable quarterly cash flow break-even in the&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/09/41008825/gene-therapy-focused-bluebird-bio-restructures-cuts-is-workforce-by-25-seeks-to-breakeven-next-ye" rel="noreferrer noopener">second half of 2025</a>.
Price Action: BLUE stock is down 11.2% at $0.32 at last check Friday.
Photo by Ground Picture on Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42012924/mullen-drives-into-government-sector-with-electric-bollinger-b4-trucks" target="_blank" rel="noreferrer noopener">Mullen Drives Into Government Sector With Electric Bollinger B4 Trucks</a></li>
</ul>

Biotech

Earnings

Equities

BLUE

JP Morgan Downgrades Gene Therapy Focused Bluebird Bio, Cites Limited Funding Options

Guggenheim analyst Michael Morris maintains Walt Disney (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) with a Buy and raises the price target from $110 to $130.

Guggenheim Maintains Buy on Walt Disney, Raises Price Target to $130

Telsey Advisory Group analyst Dana Telsey maintains Dillard's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDS#NYSE">DDS</a>) with a Market Perform and raises the price target from $380 to $450.

Telsey Advisory Group Maintains Market Perform on Dillard's, Raises Price Target to $450

General Motors Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) has reportedly laid off 1,000 employees as part of its plan to reduce costs by $2 billion by the end of 2024. This follows earlier layoffs in its software and services division and voluntary buyouts in 2023, which affected 5,000 employees according to <a href="https://www.wsj.com/business/autos/gm-cuts-another-1-000-jobs-as-ev-push-continues-21ed77c8?mod=hp_lead_pos11">The Wall Street Journal.</a>
The company cited the need to optimize operations and focus on priorities. Other automakers, including Ford Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) and Volkswagen Inc., are also cutting costs due to weak global markets and high EV development expenses.
GM continues to expand its EV lineup but expects these vehicles to remain unprofitable in 2025. Gas-powered trucks and SUVs remain the company's most profitable segment, driving <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41462946/general-motors-strong-q3-earnings-impress-analysts-highlights-turnaround-and-ev-pro">better-than-expected third-quarter </a>results last month.
What Else: Cruise, GM's autonomous vehicle division, also <a href="https://www.benzinga.com/tech/24/11/42002804/gms-autonomous-driving-unit-cruise-admits-to-falsifying-accident-report-to-nhtsa-agrees-to-pay-500k-fine">admitted to falsifying an accident</a> report to the National Highway Traffic Safety Administration. The report failed to disclose full details of an Oct. 2023 crash in San Francisco where a Cruise robotaxi dragged a pedestrian 20 feet after the individual was hit by another vehicle.
Cruise will pay a $500,000 fine, create a Safety Compliance Program and submit annual reports to avoid further penalties. The company halted U.S. operations after the incident but resumed manual driving in Phoenix, Houston and Dallas earlier this year. It plans to return to driverless operations by year-end, according to GM CEO Mary Barra.
GM Price Action: General Motors shares were down 1% at $57.05 at the time of writing, according to<a href="https://pro.benzinga.com/dashboard"> Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://benzinga.slack.com/archives/D072651PB4K/p1727794380964569"><img loading="lazy" decoding="async" width="1024" height="550" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/15132437/GM-1024x550.png" alt="" class="wp-image-651005" style="width:561px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/15132437/GM-1024x550.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/15132437/GM-300x161.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/15132437/GM-768x412.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/15132437/GM.png 1153w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/11/42015701/eyenovia-stock-sinks-as-pivotal-trial-fails-to-hit-primary-efficacy-goal-analyst-downgrades-due-to-limited-capital-and-near-term-upside-from-pipeline">Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline</a></li>
</ul>
Image via Shutterstock.

What's Going On With General Motors Today?

Guggenheim analyst Debjit Chattopadhyay maintains Centessa Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTA#NASDAQ">CNTA</a>) with a Buy and raises the price target from $24 to $28.

CNTA

Guggenheim Maintains Buy on Centessa Pharmaceuticals, Raises Price Target to $28

Telsey Advisory Group analyst Dana Telsey maintains Capri Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>) with a Market Perform and lowers the price target from $26 to $23.

CPRI

Telsey Advisory Group Maintains Market Perform on Capri Holdings, Lowers Price Target to $23

Guggenheim analyst Michael Schmidt maintains Adaptimmune Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADAP#NASDAQ">ADAP</a>) with a Buy and lowers the price target from $4 to $3.

ADAP

Guggenheim Maintains Buy on Adaptimmune Therapeutics, Lowers Price Target to $3

Western Midstream (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WES#NYSE">WES</a>) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $39.5, a high estimate of $42.00, and a low estimate of $37.00. This current average reflects an increase of 0.43% from the previous average price target of $39.33. 
<img src="https://www.benzinga.com/files/images/story/2024/1731697263_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The perception of Western Midstream by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Shneur Gershuni</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$37.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Robert Kad</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$40.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Elvira Scotto</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$41.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Shneur Gershuni</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$39.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Robert Kad</td>
<td>Morgan Stanley</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$42.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Elvira Scotto</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$38.00</td>
<td>$36.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Western Midstream. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Western Midstream compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Western Midstream's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Western Midstream's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/WES/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Western Midstream analyst ratings.</a>
<h2>All You Need to Know About Western Midstream</h2>
Western Midstream Partners LP is a US-based company which own, operate, acquire and develop midstream energy assets. The company through its subsidiary is engaged in the business of gathering, processing, compressing, treating and transporting natural gas, condensate, NGLs and crude oil. It owns or has investments in assets located in the Rocky Mountains (Colorado, Utah, and Wyoming), the Mid-Continent (Kansas and Oklahoma), North-central Pennsylvania and Texas.
<h3>Western Midstream: Financial Performance Dissected</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Western Midstream's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 13.83% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Energy sector.
Net Margin: Western Midstream's net margin excels beyond industry benchmarks, reaching 31.9%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Western Midstream's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 8.64%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Western Midstream's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.24%, the company showcases efficient use of assets and strong financial health.
Debt Management: Western Midstream's debt-to-equity ratio surpasses industry norms, standing at 2.45. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>The Significance of Analyst Ratings Explained</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Evaluating Western Midstream: Insights From 6 Financial Analysts

Applied Digital Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) stock is trading higher Friday as Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) gained exposure to the stock.
Nvidia&#8217;s <a target="_blank" href="https://www.benzinga.com//node/41990548" rel="noreferrer noopener">13F fling</a> shows it purchased 7.72 million Applied Digital shares worth $63.66 million as of September 30, 2024, which translates into close to a 3.6% stake in Applied Digital, which had 215.36 million outstanding shares as of October&nbsp;8, 2024,
Applied Digital, a U.S. company, delivers cutting-edge digital infrastructure tailored for high-performance computing and AI applications.
Also Read: <a target="_blank" href="https://www.benzinga.com/media/24/11/42008569/salesforce-loses-ai-chief-amid-major-push-for-autonomous-agents" rel="noreferrer noopener">Salesforce Loses AI Chief Amid Major Push for Autonomous Agents</a>
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="750" height="650" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/15125158/newplot-9.png" alt="" class="wp-image-650883" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/15125158/newplot-9.png 750w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/15125158/newplot-9-300x260.png 300w" sizes="(max-width: 750px) 100vw, 750px" /></figure>
Applied Digital <a target="_blank" href="https://www.benzinga.com/news/earnings/24/10/41260729/applied-digital-shares-dip-after-q1-results-details" rel="noreferrer noopener">reported a first-quarter</a> EPS loss of 15 cents, outperforming the analyst loss estimate of 29 cents. Revenue for the quarter reached $60.7 million, surpassing the expected $54.85 million.
The company attributed the revenue boost to recognizing income from its Cloud Services segment following the launch of the service at the end of the prior fiscal year.
Applied Digital had secured $160 million in September through a private placement involving institutional and accredited investors, including Nvidia.
Applied Digital planned to <a target="_blank" href="https://www.benzinga.com/news/24/09/40733450/applied-digital-corp-shares-are-trading-higher-today-what-you-need-to-know" rel="noreferrer noopener">allocate the proceeds</a> toward expanding its data centers and developing AI cloud infrastructure, strengthening its position in the AI and high-performance computing (HPC) markets.
The company is advancing a large-scale data center project in North Dakota while scaling up its cloud-computing operations.
Also, on November 4, Applied Digital <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g41728245/applied-digital-corporation-announces-closing-of-450-million-of-convertible-notes-offering" rel="noreferrer noopener">completed raising $450 million</a> via an upsized private convertible notes offering to fund share repurchases of the company&#8217;s common stock.
The filing shows Nvidia retained its stake in Arm Holdings Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>), Nano-X Imaging Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNOX#NASDAQ">NNOX</a>), Recursion Pharmaceuticals, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>), Serve Robotics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) and SoundHound AI, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>).
As of September 30, 2024, the U.S. chip designer held 1.96 million Arm shares worth $280.41 million, 0.06 million shares of Nano-X Imaging worth $0.36 million, 7.71 million Recursion Pharmaceuticals shares worth $50.78 million, 3.73 million Serve Robotics shares worth $29.63 million, and 1.73 million SoundHound AI shares worth $8.07 million.
Oppenheimer&#8217;s Rick Schafer reaffirmed his Outperform rating for Nvidia, raising the <a target="_blank" href="https://www.benzinga.com/24/11/42005107/nvidia-set-for-gains-from-ai-cloud-demand-blackwell-launch-and-data-center-expansion-analyst-notes" rel="noreferrer noopener">price target from $150 to $175</a>.
He maintains a bullish long-term outlook, emphasizing Nvidia&#8217;s leadership in AI hardware, robust margins, and strong data center ecosystem as key growth drivers.
Schafer expects Nvidia&#8217;s third-quarter results and January guidance to surpass estimates due to strong demand for AI products from cloud providers and enterprise clients.
He revised his projections upward, driven by high traction for Hopper AI accelerators and the initial ramp-up of Nvidia&#8217;s Blackwell chips in the fourth quarter.
Schafer forecasts Blackwell to generate several billion dollars in revenue in the January quarter despite supply constraints from CoWoS-L capacity.
Price Actions:&nbsp;At last check on Friday, APLD stock was up 7.73% at $7.39. NVDA stock is down 3.24%.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/24/11/42011906/exxon-mobil-set-to-cut-400-texas-jobs-after-pioneer-deal" target="_blank" rel="noreferrer noopener">Exxon Mobil To Cut 400 Texas Jobs In Stages Through 2026</a></li>
</ul>

APLD

NNOX

NVDA

RXRX

SERV

SOUN

Nvidia Reveals 3.6% Stake In Applied Digital, Stock Soars

State Street (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STT#NYSE">STT</a>) underwent analysis by 9 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated State Street and provided 12-month price targets. The average target is $100.0, accompanied by a high estimate of $108.00 and a low estimate of $87.00. This upward trend is apparent, with the current average reflecting a 5.14% increase from the previous average price target of $95.11.
<img src="https://www.benzinga.com/files/images/story/2024/1731697247_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive State Street. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mike Mayo</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$108.00</td>
<td>$106.00</td>
</tr>
<tr>
<td>Brian Bedell</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Hold</td>
<td>$95.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Jason Goldberg</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$108.00</td>
<td>$103.00</td>
</tr>
<tr>
<td>Mike Mayo</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$106.00</td>
<td>$98.00</td>
</tr>
<tr>
<td>Glenn Schorr</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$94.00</td>
<td>$89.00</td>
</tr>
<tr>
<td>Connor Lynagh</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$102.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Connor Lynagh</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$100.00</td>
<td>$93.00</td>
</tr>
<tr>
<td>Alexander Blostein</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$100.00</td>
<td>$98.00</td>
</tr>
<tr>
<td>Brian Bedell</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Hold</td>
<td>$87.00</td>
<td>$79.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to State Street. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of State Street compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of State Street's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of State Street's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/STT/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on State Street analyst ratings.</a>
<h2>About State Street</h2>
State Street is a leading provider of financial services, including investment servicing, investment management, and investment research and trading. With approximately $42 trillion in assets under custody and administration and $4.1 trillion assets under management as of Dec. 31, 2023, State Street operates globally in more than 100 geographic markets and employs more than 46,000 worldwide.
<h3>State Street: A Financial Overview</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: State Street's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 18.1%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: State Street's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 21.46%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): State Street's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 3.01%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.21%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 1.34, State Street adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>What Are Analyst Ratings?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Key Takeaways From State Street Analyst Ratings

Deep-pocketed investors have adopted a bearish approach towards Vertiv Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in VRT usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 18 extraordinary options activities for Vertiv Hldgs. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 33% leaning bullish and 55% bearish. Among these notable options, 6 are puts, totaling $836,940, and 12 are calls, amounting to $727,867.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $70.0 to $160.0 for Vertiv Hldgs over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Vertiv Hldgs's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Vertiv Hldgs's significant trades, within a strike price range of $70.0 to $160.0, over the past month.
<h3>Vertiv Hldgs Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731697244_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>VRT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/29/24</td>
<td>$3.6</td>
<td>$3.2</td>
<td>$3.49</td>
<td>$115.00</td>
<td>$350.0K</td>
<td>96</td>
<td>1.0K</td>
</tr>
<tr>
<td>VRT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/29/24</td>
<td>$4.6</td>
<td>$4.3</td>
<td>$4.49</td>
<td>$120.00</td>
<td>$193.0K</td>
<td>32</td>
<td>2.0K</td>
</tr>
<tr>
<td>VRT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$8.2</td>
<td>$8.1</td>
<td>$8.1</td>
<td>$120.00</td>
<td>$185.4K</td>
<td>605</td>
<td>295</td>
</tr>
<tr>
<td>VRT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$2.05</td>
<td>$2.0</td>
<td>$2.0</td>
<td>$120.00</td>
<td>$100.0K</td>
<td>5.3K</td>
<td>547</td>
</tr>
<tr>
<td>VRT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$4.9</td>
<td>$4.7</td>
<td>$4.85</td>
<td>$140.00</td>
<td>$96.9K</td>
<td>2.4K</td>
<td>215</td>
</tr>
</tbody>
</table>

<h3>About Vertiv Hldgs</h3>
Vertiv Holdings Co brings together hardware, software, analytics and ongoing services to ensure its customers vital applications run continuously, perform optimally and grow with their business needs. The company solves the important challenges faced by data centers, communication networks and commercial and industrial facilities with a portfolio of power, cooling and IT infrastructure solutions and services that extends from the cloud to the edge of the network. Its services include critical power, thermal management, racks and enclosures, monitoring and management, and other services. Its three business segments include the Americas, Asia Pacific; and Europe, Middle East &amp; Africa.
<h3>Current Position of Vertiv Hldgs</h3>
<ul>
<li>Currently trading with a volume of 3,912,933, the VRT's price is down by -0.88%, now at $119.96. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 96 days.</li>
</ul>
<h3>Expert Opinions on Vertiv Hldgs</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $129.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Evercore ISI Group persists with their Outperform rating on Vertiv Hldgs, maintaining a target price of $135. 
&#x2A; Maintaining their stance, an analyst from TD Cowen continues to hold a Buy rating for Vertiv Hldgs, targeting a price of $115. 
&#x2A; An analyst from UBS has revised its rating downward to Buy, adjusting the price target to $155. 
&#x2A; Consistent in their evaluation, an analyst from Mizuho keeps a Outperform rating on Vertiv Hldgs with a target price of $110. 
&#x2A; An analyst from Citigroup has decided to maintain their Buy rating on Vertiv Hldgs, which currently sits at a price target of $134. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Vertiv Hldgs options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Markets

Unpacking the Latest Options Trading Trends in Vertiv Hldgs

Investors with a lot of money to spend have taken a bearish stance on RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with RH, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 10 uncommon options trades for RH.
This isn't normal.
The overall sentiment of these big-money traders is split between 10% bullish and 80%, bearish.
Out of all of the special options we uncovered, 2 are puts, for a total amount of $106,519, and 8 are calls, for a total amount of $298,502.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $310.0 to $500.0 for RH over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of RH stands at 59.0, with a total volume reaching 242.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in RH, situated within the strike price corridor from $310.0 to $500.0, throughout the last 30 days.
<h3>RH Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731697239_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>RH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/13/24</td>
<td>$25.4</td>
<td>$23.9</td>
<td>$23.69</td>
<td>$320.00</td>
<td>$73.0K</td>
<td align="right">0</td>
<td align="right">38</td>
</tr>
<tr>
<td>RH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/29/24</td>
<td>$16.2</td>
<td>$11.5</td>
<td>$16.2</td>
<td>$322.50</td>
<td>$72.9K</td>
<td align="right">85</td>
<td align="right">45</td>
</tr>
<tr>
<td>RH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$25.9</td>
<td>$25.0</td>
<td>$25.0</td>
<td>$500.00</td>
<td>$50.0K</td>
<td align="right">147</td>
<td align="right">54</td>
</tr>
<tr>
<td>RH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$28.8</td>
<td>$25.2</td>
<td>$25.3</td>
<td>$500.00</td>
<td>$35.4K</td>
<td align="right">147</td>
<td align="right">54</td>
</tr>
<tr>
<td>RH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$70.5</td>
<td>$70.0</td>
<td>$70.0</td>
<td>$310.00</td>
<td>$35.0K</td>
<td align="right">0</td>
<td align="right">5</td>
</tr>
</tbody>
</table>

<h3>About RH</h3>
RH is a luxury furniture and lifestyle retailer operating in the $134 billion domestic furniture and home furnishing industry. The firm offers merchandise across many categories including furniture, lighting, textiles, bath, decor, and children and is growing the presence of its hospitality business with 18 restaurant locations. RH innovates, curates, and integrates products, categories, services, and businesses across channels and brand extensions (RH Modern and Waterworks, for example). RH is fully integrated across channels and is positioned to broaden its addressable market over the next decade by expanding abroad, with its World of RH digital platform (highlighting offerings outside of home furnishings), and with offerings in color, bespoke furniture, architecture, media, and more.
<h3>Where Is RH Standing Right Now?</h3>
<ul>
<li>With a trading volume of 199,342, the price of RH is down by -2.24%, reaching $315.58.</li>
<li>Current RSI values indicate that the stock is may be approaching oversold.</li>
<li>Next earnings report is scheduled for 20 days from now.</li>
</ul>
<h3>What Analysts Are Saying About RH</h3>
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $430.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Wedbush has elevated its stance to Outperform, setting a new price target at $430. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for RH with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

RH Unusual Options Activity For November 15

IPO Roundup: Games Global, RF Acquisition, and more

Raytech Holding Limited (RAY) has released an update. Raytech Holding Limited has entered into an underwriting agreement with Revere Securities LLC...

Raytech Holding Announces New Share Offering

U.S. IPO Weekly Recap: Hot Pot Chain Leads The Week's IPOs As The Pipeline Gets A Billion-Dollar Boost

Sea, DraftKings, Sasol among premarket losers' pack

Wall Street Breakfast: The Week Ahead

Raytech announces a rise in 2024 revenue

Raytech Holding Limited (RAY) has released an update. Raytech Holding Limited, a Hong Kong-based personal care electrical appliance company, has an...

Raytech Seals IPO Over-Allotment, Boosts Capital

Raytech Holding Limited (RAY) has released an update. Raytech Holding Limited has announced its upcoming annual shareholder meeting scheduled for O...

Raytech Holding Announces Upcoming Shareholder Meeting

Raytech Holding Limited (RAY) has released an update. Raytech Holding Limited has introduced its 2024 Equity Incentive Plan aimed at enhancing long...

Raytech Holding Limited Launches 2024 Equity Incentive Plan

Walt Disney, Cisco, And Shopify Headline Latest Earnings Week

AAPL

ADBE

AKAN

ALCN

AMAT

AMZN

ANGI

ARMK

AVGO

BABA

BBWI

BCTX

BEKE

BTOC

CASY

CPRT

CSCO

CVGW

CYBR

CYTO

DKNG

EVGO

EXTR

FCEL

GALE

GROY

HLIT

JDZG

KDLY

KNOP

LAZR

LICN

MINM

MLGO

MRAI

NRDY

ONMD

ORCL

PAVS

PAYO

PLAY

PLCE

QRVO

RBRK

REGN

RFAIU

RMLFF

RNAZ

RSHL

SHIM

SHOP

SPHIF

SPOT

SPWR

STLA

SWIN

TALO

TSEM

TSLA

WELL

YEXT

YUMC

ZETA

Press Releases

Raytech Holding Limited Announces Pricing of Its Initial Public Offering

Raytech Holding: Making Nasdaq Debut as It Pioneers Personal Care Electrical Appliances in a Booming Market

Raytech Holding Limited Announces Closing of $6 Million Initial Public Offering

Raytech Holding Pre-announces Preliminary Key Financial Matric for 2024

Raytech Holding Limited Announces Closing of the Underwriters' Over-Allotment Option in Connection with its Initial Public Offering

Raytech Holding Reports Financial Results for Fiscal Year Ended March 31, 2024

Raytech Holding Limited Announces Results of 2024 Annual Meeting of Shareholders

Comments

Raytech Holding

Noticias

Últimas noticias sobre Raytech Holding (NASDAQ:RAY) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL